Cite the Following Article
Protein–protein interactions in bacteria: a promising and challenging avenue towards the discovery of new antibiotics
Laura Carro
Beilstein J. Org. Chem. 2018, 14, 2881–2896.
https://doi.org/10.3762/bjoc.14.267
How to Cite
Carro, L. Beilstein J. Org. Chem. 2018, 14, 2881–2896. doi:10.3762/bjoc.14.267
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Presentation Graphic
| Picture with graphical abstract, title and authors for social media postings and presentations. | ||
| Format: PNG | Size: 1.3 MB | Download |
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Melotti, E.; Delerue, T.; Gomperts Boneca, I. Understanding how bacterial cell wall peptidoglycan metabolism can be used to develop antimicrobial strategies. Expert opinion on therapeutic targets 2026, 29, 1–810. doi:10.1080/14728222.2025.2608020
- Bista, S.; Brangulis, K.; Bhattachan, B.; Foor, S. D.; Ronzetti, M. H.; Jain, S.; Miller, J.; Subramanion, J. L.; Kitsou, C.; Rana, V. S.; Rai, G.; Zakharov, A. V.; Simeonov, A.; Baljinnyam, B.; Pal, U. Targeting of interaction between BB0323-BB0238 informs new paradigms in Lyme disease therapeutics. PLoS pathogens 2026, 22, e1013805. doi:10.1371/journal.ppat.1013805
- Agassy, C.; Samuel, B.; Mayo, S.; Zorea, A.; Burstein, D. B-PPI: A Cross-Attention Model for Large-Scale Bacterial Protein-Protein Interaction Prediction. openRxiv 2025. doi:10.64898/2025.12.23.696145
- Sahoo, P. R.; Kumar, A.; Pashupathi, M.; Sahoo, J. R.; Behera, P.; Saxena, M. Protein protein Interactions of NarL with NarG, SsrB, and FNR Proteins in Salmonella Typhimurium: A Comparative Analysis. Current microbiology 2025, 83, 17. doi:10.1007/s00284-025-04609-z
- Maj, P.; Trylska, J. Protein-Protein Interactions as Promising Molecular Targets for Novel Antimicrobials Aimed at Gram-Negative Bacteria. International journal of molecular sciences 2025, 26, 10861. doi:10.3390/ijms262210861
- van Wier, S. P.; Beekman, A. M. Peptide design to control protein-protein interactions. Chemical Society reviews 2025, 54, 1684–1698. doi:10.1039/d4cs00243a
- Bollati, M.; Fasola, E.; Pieraccini, S.; Freddi, F.; Cocomazzi, P.; Oliva, F.; Klußmann, M.; Maspero, A.; Piarulli, U.; Ferrara, S.; Pellegrino, S.; Bertoni, G.; Gazzola, S. Impairing protein-protein interactions in an essential tRNA modification complex: An innovative antimicrobial strategy against Pseudomonas aeruginosa. Journal of peptide science : an official publication of the European Peptide Society 2024, 31, e3658. doi:10.1002/psc.3658
- Cruz-Bautista, R.; Zelarayan-Agüero, A.; Ruiz-Villafán, B.; Escalante-Lozada, A.; Rodríguez-Sanoja, R.; Sánchez, S. An overview of the two-component system GarR/GarS role on antibiotic production in Streptomyces coelicolor. Applied microbiology and biotechnology 2024, 108, 306. doi:10.1007/s00253-024-13136-z
- Gómez Borrego, J.; Torrent Burgas, M. Structural assembly of the bacterial essential interactome. eLife 2024, 13. doi:10.7554/elife.94919
- Chengan, K.; Hind, C.; Stanley, M.; Wand, M. E.; Nagappa, L. K.; Howland, K.; Hanson, T.; Martín-Escolano, R.; Tsaousis, A. D.; Bengoechea, J. A.; Mark Sutton, J.; Smales, C. M.; Moore, S. J. A cell-free strategy for host-specific profiling of intracellular antibiotic sensitivity and resistance. npj antimicrobials and resistance 2023, 1, 16. doi:10.1038/s44259-023-00018-z
- Halawa, M.; Akantibila, M.; Reid, B. E.; Carabetta, V. J. Therapeutic proteins have the potential to become new weapons in the fight against antibiotic resistance. Frontiers in Bacteriology 2023, 2. doi:10.3389/fbrio.2023.1304444
- Murugesan, J.; Mubarak, S. J.; Vedagiri, H. Design of novel anti-quorum sensing peptides targeting LuxO to combat Vibrio cholerae pathogenesis. In silico pharmacology 2023, 11, 30. doi:10.1007/s40203-023-00172-2
- Chen, J.; Kuhn, L. A.; Raschka, S. Techniques for Developing Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots. Methods in molecular biology (Clifton, N.J.) 2023, 2714, 235–268. doi:10.1007/978-1-0716-3441-7_14
- Gómez Borrego, J.; Torrent, M. B. Structural assembly of the bacterial essential interactome. Cold Spring Harbor Laboratory 2023. doi:10.1101/2023.06.14.544900
- Chengan, K.; Hind, C.; Nagappa, L.; Wand, M. E.; Hanson, T.; Escolano, R. M.; Tsaousis, A.; Bengoechea, J. A.; Mark Sutton, J.; Smales, C. M.; Moore, S. J. A cell-free strategy for profiling intracellular antibiotic sensitivity and resistance. Cold Spring Harbor Laboratory 2023. doi:10.1101/2023.04.13.536698
- Catara, G.; Caggiano, R.; Palazzo, L. The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies. Pathogens (Basel, Switzerland) 2023, 12, 240. doi:10.3390/pathogens12020240
- Chen, J.; Kuhn, L. A.; Raschka, S. Techniques for Developing Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots. Cold Spring Harbor Laboratory 2022. doi:10.1101/2022.12.26.521948
- Yu, W.; Weber, D. J.; MacKerell, A. D. Computer-Aided Drug Design: An Update. Methods in molecular biology (Clifton, N.J.) 2022, 2601, 123–152. doi:10.1007/978-1-0716-2855-3_7
- Gómez Borrego, J.; Torrent Burgas, M. Analysis of Host-Bacteria Protein Interactions Reveals Conserved Domains and Motifs That Mediate Fundamental Infection Pathways. International journal of molecular sciences 2022, 23, 11489. doi:10.3390/ijms231911489
- Champney, S. Macromolecular Structure Assembly as a Novel Antibiotic Target. Antibiotics (Basel, Switzerland) 2022, 11, 937. doi:10.3390/antibiotics11070937
Patents
- QUEMARD ANNAÏK; BARDOU FABIENNE; BORIES PASCALINE; DUCOUX-PETIT MANUELLE; ROCHE PHILIPPE; CONSTANT PATRICIA; TRANIER SAMUEL; BON CÉCILE; MOUREY LIONEL; MARCOUX JULIEN. INNOVATIVE MOLECULES DECREASING VIRULENCE OF MYCOBACTERIUM FOR THE TREATMENT OF TUBERCULOSIS. EP 4296674 A1, Dec 27, 2023.